Did You See Hakeem Jeffries' Latest Social Media Trainwreck?
There's Someone Else Who Should Be Investigated Over the Russian Collusion Hoax, But...
Scott Bessent Couldn't Stay Quiet Over This Atrocious Smear of the Trump Reconciliation...
Supreme Court Slaps Down a Federal Judge on Deportations, but There's Another Issue
Sailing on the Based Boat
Brennan, Comey, and the Reckoning Long Overdue
Disturbing Glimpses of Democratic Anger
1775: A Very Good Year for a Little Revolution
Miami’s Freedom Tower Is the New Statue of Liberty
Judge Accused of Aiding Illegal Immigrant Gets Some Bad News From Federal Magistrate...
Give the House Freedom Caucus the Credit It Deserves
Criminals Fear the Death Penalty More Than Life in Prison
The More Things Change
Is Weather the Next Weapon of Mass Destruction?
Still No Accountability for Lawfare by DOJ
Tipsheet

Johnson & Johnson Reportedly Halted Production of Its COVID-19 Vaccine

AP Photo/Matt Rourke

Johnson & Johnson reportedly shut down production of their Wuhan coronavirus vaccine at their plant in South Holland, Netherlands. Reportedly, the facility was the only plant making usable batches of the vaccine.

Advertisement

The New York Times reported Tuesday that people familiar with the situation said that the facility is making an experimental, but potentially more profitable, vaccine to protect against an unrelated virus.

“The halt is temporary – the Leiden plant is expected to start churning out the Covid vaccine again after a pause of a few months – and it is not clear whether it has an impact on vaccine supplies yet, thanks to stockpiles,” the report said.

The Times claimed that the pause in production could reduce the supply of the J&J vaccine by “a few hundred million doses, according to one of the people familiar with the decision.”

“Other facilities have been hired to produce the vaccine but either aren’t up and running yet or haven’t received regulatory approval to send what they’re making to be bottled,” the report added. “Inside Johnson & Johnson’s executive suites, the decision to suspend production at Leiden prompted concerns that it would impair the company’s ability to deliver on its vaccine commitments to the developing world.”

The J&J COVID-19 vaccine, which was a single-shot regimen, “fell out of favor” in the United States and other countries in part due to a link to a rare, though dangerous, blood-clotting disorder.

Advertisement

“But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including Omicron, when given as a two-shot regimen,” the report continued. “As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.”

In the United States, residents have a choice between the Johnson & Johnson, Pfizer, or Moderna vaccine. The latter two are a two-shot primary vaccine regimen.

In an email to The Times, a Johnson & Johnson spokesperson said the company is “focused on ensuring our vaccine is available where people are in need” and they are “working day and night” to help fight the pandemic.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement